Study of Smoking Trajectory in Newly Diagnosis Lung Cancer Patients
NCT ID: NCT03642041
Last Updated: 2018-08-22
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
406 participants
OBSERVATIONAL
2014-05-24
2018-07-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
2. Explore the related factors of the smoking change patterns.
3. The type of smoking trajectory impact on survival and quality of life.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Survival Outcomes of Lung Cancer
NCT03647098
Differences in the Presentation Outcome and Response to Treatment Between Never- Smokers and Smokers With NSCLC
NCT00483015
Evaluation of Lung Cancer CT Screening Performance Among Former and Current Smokers
NCT05486455
Studies Examining the Importance of Smoking After Being Diagnosed With Lung Cancer
NCT01192256
Non-small Cell Lung Cancer and Quality of Life
NCT00818402
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
smoking
smoking behavior
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Newly diagnosed lung cancer
* Conscious clear and able to communicate
* Agreed to participate the study
Exclusion Criteria
* Cognitive or psychotic disorders
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
National Defense Medical Center, Taiwan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Yang Chia Chen
Principal Investigator
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TWNA-1042011
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.